USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Etidronate Disodium Tablets

BRIEFING

Etidronate Disodium Tablets. This proposal is based on the version of the monograph official as of May 1, 2020. It is proposed to omit this monograph for the following reasons:

  1. No drug products formulated as defined under Etidronate Disodium Tablets are currently marketed in the United States.

  2. The drug product is currently not on the list for approved veterinary medicine in the United States.

 (SM3: N. Myers)

 Correspondence Number—C326116

This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!